Ubrolexin

Treatment of clinical mastitis

Description

PDF Product Sheet UBROLEXIN INJ

Composition
Cefalexine (as monohydrate) 200 mg
Kanamycine (as monosulphate) 100.000 IU
Indications

Treatment of clinical mastitis in lactating cows caused by bacteria sensitive to the combination of cefalexin and kanamycin such as Staphylococcus aureus, Streptococcus dysgalactiae, Streptococcus uberis and Escherigia coli.